Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
11/2007
11/29/2007CA2651732A1 Intracellular kinase inhibitors
11/29/2007CA2650795A1 Novel microbiocides
11/29/2007CA2649913A1 N-benzoyl- and n-benzylpyrrolidin-3-ylamines as histamine-3 antagonists
11/29/2007CA2646186A1 Small molecule apoptosis promoters
11/28/2007EP1858890A1 Novel antithrombotic substituted pyrrolidinones, the production and use thereof in the form of medicaments
11/28/2007EP1858866A1 Pyroglutamate salts and their use in the optical resolution of intermediates for the synthesis of dextrocetirizine and levocetirizine
11/28/2007EP1858846A1 Dpp-iv inhibitors
11/28/2007EP1858840A2 Analogs of 4-hydroxyisoleucine and uses thereof
11/28/2007EP1654225A4 Melanin concentrating hormone receptor antagonists
11/28/2007EP1438041B1 Spermicides
11/28/2007CN101080415A Organometallic compounds and processes for preparation thereof
11/28/2007CN101080375A Method for cleaning deposits from equipment that have accumulated during a method for recovering nmp by the introduction of hot water and agitation
11/28/2007CN101077875A Boronic ester and acid compounds, synthesis and uses
11/28/2007CN100351253C Pyrrolo [2,3-d] pyrimidine compounds as immunosuppressive agents
11/28/2007CN100351252C Novel process for the synthesis of carboxylic acid phenylamide
11/28/2007CN100351234C Bis-heterocyclic compounds with antitumour and chemosensitising activity
11/28/2007CN100351232C Anti-obesity agent
11/28/2007CN100351231C Lipid metabolism improving agent
11/28/2007CN100351230C Urea of N-heterocyclic carboxylic acid or the isostere of carboxylic acid and aminocarboxylic acid ester
11/27/2007US7301028 Mitotic kinesin inhibitors
11/27/2007US7300956 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
11/27/2007US7300936 α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors
11/27/2007US7300473 For dyeing keratin fibres which are capable of giving more intense and yet unselective colorations which show good resistance to the various attacking factors to which the hair may be subjected
11/22/2007WO2007133597A1 Crystalline form of atorvastatin calcium stable after storage
11/22/2007WO2007132472A1 A crystalline form b4 of atorvastatin magnesium and a process thereof
11/22/2007WO2007131929A1 Process for continuously preparing n- ethyl-2-pyrrolidone (nep)
11/22/2007WO2007131680A1 Insecticidal benzamidines
11/22/2007WO2007131528A1 Process for preparing c5 intermediates and their use in the preparation of n-substituted pyrrole derivatives
11/22/2007WO2007078990A3 Modified lysine-mimetic compounds
11/22/2007US20070270596 from gamma-butyrolactone and monoalkylamine in liquid phase, heating reaction mixture, withdrawing product stream and passing to distillation zone comprising column operated at sub-atmospheric pressure, adding water, isolating overhead stream and condensing against water
11/22/2007US20070270593 reaction product of 2,3-dihydro-4-venylbenzofuran, deprotonated 1,2-cyclohexanediamino-N,N'-bis(3,5-di-t-butyl-salicylidene) and RuCl2(p-cymene)]2; use for cyclization catalyst
11/22/2007US20070270475 4-Methoxy-Pyrrolidine-2-Carboxylic Acid Compounds and Derivatives Thereof as Hepatitis C Virus Inhibitors
11/22/2007US20070270473 Sulfonamide Compounds and Uses Thereof
11/22/2007US20070270472 Amino, Amino Acid or Peptide Conjugates of Retinoic Acid
11/22/2007US20070270471 Compounds Which Potentiate Glutamate Receptor and Uses Thereof in Medicine
11/22/2007US20070270404 Tuberculosis treatment using pleuromutilin derivatives
11/22/2007CA2652412A1 Process for preparing c5 intermediates and their use in the preparation of n-substituted pyrrole derivatives
11/22/2007CA2649708A1 Crystalline form of atorvastatin calcium stable after storage
11/21/2007EP1857455A1 Cinnamoyl compound and use thereof
11/21/2007EP1857442A2 Novel antimycobacterial compounds
11/21/2007EP1856102A1 Medicaments for alzheimer
11/21/2007EP1856096A2 Phenylglycinamide derivatives useful as anticoagulants
11/21/2007EP1856063A1 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases
11/21/2007EP1856044A2 Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
11/21/2007EP1856043A1 1-h-pyrrole-2-carboxamides and imidazole-5-carboxamides and use thereof as fak, kdr and tie2 kinase modulators for the treatment of cancer
11/21/2007EP1856042A2 Substituted gamma lactams as therapeutic agents
11/21/2007EP1856041A1 Crystallisation and purification of glycopyrronium bromide
11/21/2007EP1856032A1 Heterocyclic-substituted alkanamides useful as renin inhibitors
11/21/2007EP1758855B1 Process for preparing 2-oxo-1-pyrrolidine derivatives by intramolecular allylation
11/21/2007EP1455777B1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
11/21/2007EP1150996B1 New amidinobenzylamine derivatives and their use as thrombin inhibitors
11/21/2007CN101076515A Novel process for the manufacture of 3-pyrrolidin-2-yl-propionic acid derivatives
11/21/2007CN100350036C Apparatus and method for controlling biofilms
11/20/2007US7297808 Statin derivatives
11/20/2007US7297713 Cyanopyrrole-phenyl amide progesterone receptor modulators and uses thereof
11/20/2007US7297712 Coupling an aliphatic bromide with an aliphatic alkylamine, protecting both terminal primary alcohol groups of aliphatic alcohol, reacting both intermediates, quaternizing the product, passing quaternized product through a chroamtograph
11/20/2007US7297704 such as: N-[(6-fluoro-2,3,4,9-tetrahydro-1H-carbazol-2-yl)methyl]-N-{[(2S)-8-methyl-2,3-dihydro[1,4]dioxino[2,3-f]quinolin-2-yl]methyl}amine; binding to or antagonizing the 5-HT1A receptors
11/20/2007US7297692 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them
11/20/2007CA2536608C New highly selective process for the preparation of enantiomerically pure phenyl-substituted 1,4-dihydropyridine-3,5-dicarboxylic acid derivatives
11/20/2007CA2206362C Substituted 1-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
11/15/2007WO2007130898A1 TETRASUBSTITUTED UREAS AS MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1
11/15/2007WO2007130616A2 Polyamides for treating human papilloma virus
11/15/2007WO2007129725A1 Agent for preventing liver disease
11/15/2007WO2007128873A1 A method for the preparation of maleimido derivatives of biomolecule labeling reactants and conjugates derived thereof
11/15/2007WO2007128460A1 Substituted 3 -amino-4 -hydroxy pyrrolidines compounds, their preparation and use as medicaments
11/15/2007WO2007109578A3 Substituted gamma lactams as prostaglandin ep2 agonists
11/15/2007WO2007056469A3 Certain chemical entities, compositions, and methods
11/15/2007WO2007052296A3 A process of preparing amorphous atorvastatin calcium
11/15/2007WO2007000505A3 Derivatives of 4,5-diarylpyrrole, preparation method thereof and use of same in therapeutics
11/15/2007US20070265456 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
11/15/2007US20070265331 Such as (2S)-2-(3(S)-Acetylamino-3-((S)-sec-butyl)-2-oxo-pyrrolidin-1-yl)-N-[(1S,2R)-1-(3,5-difluoro-benzyl)-2-hydroxy-3-(3-methoxy-benzylamino)-propyl]-4-phenyl-butyramide; inhibit processing of amyloid precursor proteins
11/15/2007US20070265320 (2S,4S)-1-[[(4-carbamoylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile, for treating type II diabetes; increase glucagon-like peptide activity
11/15/2007US20070265302 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
11/15/2007US20070265268 inhibiting heat shock protein 90 (Hsp90) family protein comprising administering benzoic acid derivatives or prodrugs, for the treatment of breast cancer or leukemia
11/15/2007US20070265262 viricides selecting from a group of compounds, carbamoyl-pyrrolidine-1-carboxylic acid benzyl ester derivatives; treating or preventing a viral infection; 2-(2',4'-Dimethoxy-biphenyl-4-ylcarbamoyl)-pyrrolidine-1-carboxylic acid benzyl ester
11/15/2007US20070265254 Naphthaline derivatives as H3 inverse agonists
11/15/2007US20070265248 Substituted piperazines and methods of use
11/15/2007US20070265240 Sequence Selective Pyrrole and Imidazole Polyamide Metallocomplexes
11/15/2007US20070264217 3-(2-hydroxyphenyl)-2-propenamides that react to form a lactone and an amine; laundry detergents, perfumes, shampoos and hair conditioners
11/15/2007CA2649677A1 Tetrasubstituted ureas as modulators of 11-.beta. hydroxyl steroid dehydrogenase type 1
11/14/2007EP1854784A1 Activator for peroxisome proliferator activating receptor
11/14/2007EP1853559A1 An improved process for the preparation of atorvastatin and intermediates
11/14/2007EP1853558A1 Process for producing atorvastatin hemicalcium
11/14/2007EP1853557A2 1,5-diarylpyrrole derivatives, preparation method thereof and application of same in therapeutics
11/14/2007EP1427722B1 Pyrrole-type compounds, compositions, and methods for treating cancer, treating viral diseases and causing immunosuppression
11/14/2007CN101072773A Pyrrole derivatives having CRTH2 receptor antagonist activity
11/14/2007CN101072761A 2-alkyl-cycloalk(en)yl-carboxamides
11/14/2007CN101070317A Heterocyclic derivatives, composition containing same and method for pests control
11/14/2007CN101070301A Dicarboxy Boc-L drivative, its preparing method and use
11/14/2007CN101070300A Linonene anologs and its preparing method and use
11/13/2007US7294722 Process for the synthesis of peptides containing a 4-hydroxy-proline substructure
11/13/2007US7294719 Reacting an amino acid with mono-, di- and/or triphosgene to produce an N-carboxyanhydride as a product and HCl as a by-product, while passing a purge gas through the reaction mixture; reducing the concentration of the phosgene reactant from the purge gas after the reaction
11/13/2007US7294649 Methamphetamine derivatives and conjugates for immunoassay
11/13/2007US7294647 Kappa agonist compounds and pharmaceutical formulations thereof
11/13/2007US7294644 CB 1 receptor inverse agonists
11/13/2007US7294642 1,3-Diamino-2-hydroxypropane pro-drug derivatives
11/13/2007US7294637 Such as [1-(4-chloro-phenyl)-cyclobutyl]-(3-hydroxymethyl piperidin-1-yl)-methadone for treating cocaine and/or methamphetamine addiction
11/13/2007US7294369 Polymerisable cinnamates with lateral substitution
11/13/2007CA2345006C New benzoylguanidine derivatives with advantageous properties, processes for preparing them and their use in the production of pharmaceutical compositions
11/13/2007CA2248304C Surface modified carbonate materials
1 ... 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 ... 404